The number of people with diabetes or pre-diabetes who are candidates for drugs has been magnified by organizations and doctors with financial ties to drug companies, the Journal Sentinel/MedPage Today investigation found.
About one-third of people with type 1 diabetes produce insulin, as measured by C-peptide, a byproduct of insulin production, even upward of forty years from initial diagnosis, according to a first-of-its-kind, large-scale study conducted by researchers from T1D Exchange. This sheds new light on the long-accepted belief that these patients lose all ability to produce any insulin; this could have significant policy implications. The findings were published online this week in Diabetes Care.
Columbia University Medical Center has presented Andrew Hattersley, DM, and Mark McCarthy, MD, with the 16th Naomi Berrie Award for Outstanding Research in Diabetes, for their work on the genetics of the disease. Their research has contributed to the discovery of new forms of the disease, improvements in diagnostic methodology, and the development of more effective treatments.
The Jutland peninsula in Denmark provides half the world’s supply of insulin, the life-saving pancreatic hormone that regulates blood sugar levels. And Novo Nordisk, the Danish company is the largest global supplier. For more than a decade Novo’s
The Food and Drug Administration’s reporting system provides only a partial view of the potentially dangerous side effects of the drugs it approves every year. This is particularly important for diabetes.
In the late hours of Monday, December 1st, I received a heartbreaking call from my mother telling me that she had just lost her home to an electrical fire. It started on the first floor and spread up a wall to their second floor bedroom. My mom and step-dad were in bed at the time and barely ma...
A recent study published in the journal PNAS shows that young capillary vessels rejuvenate aged pancreatic islets. The finding challenges prevailing views on the causes of age-dependent impaired glucose balance regulation, a condition that often develops into diabetes type 2. The international research ...